Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis

医学 多发性骨髓瘤 自体干细胞移植 移植 内科学 肿瘤科 回顾性队列研究 干细胞 外科 生物 遗传学
作者
Kazuhito Suzuki,Shohei Mizuno,Yutaka Shimazu,Shin‐ichi Fuchida,Shotaro Hagiwara,Mitsuhiro Itagaki,Kaichi Nishiwaki,Akira Hangaishi,Takahiro Karasuno,Taku Kikuchi,Misayo Shimizu,Akinori Nishikawa,Takeshi Kobayashi,Kazutaka Sunami,Nobuhiro Hiramoto,Hitoji Uchiyama,Yumiko Maruyama,Yoshinobu Kanda,Tatsuo Ichinohe,Yoshiko Atsuta
出处
期刊:European Journal of Haematology [Wiley]
卷期号:110 (4): 444-454 被引量:6
标识
DOI:10.1111/ejh.13922
摘要

Tandem autologous stem cell transplantation (ASCT) has been reconsidered for high-risk patients with myeloma, and the eligibility criteria for up-front ASCT have been updated to include more elderly patients. This study aimed to evaluate the efficacy and tolerability of tandem ASCT in elderly patients with myeloma compared to tandem ASCT in young patients and single ASCT in elderly patients. A retrospective study using the Transplant Registry Unified Management Program database of the Japanese Society for Transplantation and Cellular Therapy, which included 64 elderly and 613 young patients who received tandem ASCT, and 891 elderly patients who received single ASCT, was conducted. The median overall survival (OS) over 38.5 months in the elderly and young patients who received tandem ASCT, and elderly patients who received single ASCT was 78.9, 92.5, and 77.1 months, respectively; no significant difference in the median OS was observed. The cumulative incidence of transplantation-related mortality was similar in the elderly and young patients receiving tandem ASCT. High-risk cytogenetic abnormality was not identified as a poor prognostic factor for OS in elderly patients who received tandem ASCT but in those who received single ASCT. Thus, tandem ASCT was effective and tolerable in elderly patients with myeloma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
毕不了业要赔钱完成签到,获得积分10
1秒前
小y完成签到,获得积分10
1秒前
lisastream完成签到,获得积分10
1秒前
dian完成签到,获得积分10
2秒前
无花果的应助被XPR采纳,获得10
2秒前
2秒前
虫子完成签到,获得积分10
5秒前
5秒前
hkh完成签到,获得积分10
6秒前
科研通AI65的应助被迷路的夏之采纳,获得10
7秒前
Lucas的应助被原点采纳,获得10
7秒前
7秒前
淡然紫菜完成签到,获得积分10
8秒前
8秒前
deardorff完成签到,获得积分10
9秒前
冷静勒完成签到,获得积分10
9秒前
哈基米完成签到,获得积分0
10秒前
荣荣发布了新的文献求助10
11秒前
11秒前
田様的应助被huwenbin采纳,获得10
11秒前
111完成签到,获得积分10
12秒前
12秒前
12秒前
12秒前
fantasy的应助被王大橙子采纳,获得10
13秒前
13秒前
znznznzn1234发布了新的文献求助10
14秒前
迷路的夏之完成签到,获得积分10
15秒前
Steven完成签到 ,获得积分10
16秒前
XPR发布了新的文献求助10
17秒前
fantasy的应助被科研小虫采纳,获得10
17秒前
18秒前
18秒前
194完成签到,获得积分10
19秒前
cscgood完成签到,获得积分10
20秒前
dzy完成签到,获得积分10
20秒前
落叶完成签到,获得积分10
20秒前
yy完成签到 ,获得积分10
21秒前
21秒前
DW的应助被紫薇的星辰采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181823
求助须知:如何正确求助?哪些是违规求助? 9571511
关于积分的说明 21818391
捐赠科研通 7778076
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479614